当前位置: 首页 > 期刊 > 《中国药房》 > 20189
编号:13587120
海南省汉族人群HLA—B*5801基因多态性与别嘌醇所致不良反应的相关性研究(4)
http://www.100md.com 2018年5月1日 《中国药房》 20189
     [11] WATERS LJ,MANDALIA S,GAZZARD B,et al. Prospective HLA-B*5701 screening and abacavir hypersensitivity:a single centre experience[J]. Aids,2007,21(18):2533-2534.

    [12] KHANNA D,FITZGERALD JD,KHANNA PP,et al. 2012 American college of rheumatology guidelines for management of gout. Part 1:systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia[J]. Arthritis Care Res,2012,64(10):1431-1446.

    [13] GONZ?LEZGALARZA FF,TAKESHITA LY,SANTOS EJ,et al. Allele frequency net 2015 update:new features for HLA epitopes,KIR and disease and HLA adverse drug reaction associations[J]. Nucleic Acids Res,2015,43(D1):D784-D788.

    [14] 吳国光,邓志辉,高素青,等. 6965名汉族骨髓供者HLA多态性分析[J].中华血液学杂志,2004,25(8):473-477.

    [15] GUEUDRY J,ROUJEAU JC,BINAGHI M,et al. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis[J]. Arch Dermatol,2009,145(2):157-162.

    (收稿日期:2017-11-06 修回日期:2018-02-11)

    (编辑:邹丽娟), http://www.100md.com(云雄 吴丹娜 韩方璇 黄春新 彭文兴)
上一页1 2 3 4